Analysis of Dominant-Negative Effects of Mutant Env Proteins of Human Immunodeficiency Virus Type 1  by Iwatani, Yasumasa et al.
s
e
1
c
i
Virology 286, 45–53 (2001)
doi:10.1006/viro.2001.0944, available online at http://www.idealibrary.com onAnalysis of Dominant-Negative Effects of Mutant Env Proteins
of Human Immunodeficiency Virus Type 1
Yasumasa Iwatani,*,1 Kumi Kawano,† Takaharu Ueno,† Masakazu Tanaka,†
Akinori Ishimoto,† Masahiko Ito,* and Hiroyuki Sakai†,2
*Department of Microbiology, Yamanashi Medical University, Tamaho-cho, Yamanashi 409-3898, Japan; and †Department of Viral Oncology,
Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
Received September 9, 2000; returned to author for revision January 9, 2001; accepted March 26, 2001
The Env protein of human immunodeficiency virus type 1 is assembled into a stable trimer, and oligomerization is required
for maintenance of viral infectivity. This property of Env suggests that Env mutants may have a dominant-negative effect on
virus infectivity. To investigate this possibility, we established a packaging cell line in which both wild-type and mutant Env
proteins could be expressed simultaneously in a single cell. We analyzed the effects of two types of Env mutants: cytoplasmic
tail-truncated TM mutants and a mutant defective in gp120/gp41 cleavage. The cytoplasmic tail-truncated proteins were
found to be incorporated into virions by forming an oligomer with wild-type TM, but could not inhibit the wild-type function.
In contrast, phenotypic mixing of cleavage-defective Env with the wild-type protein caused dramatic inhibition of infectivity,
indicating that this mutant has a strong dominant-negative phenotype. © 2001 Academic Press
Key Words: HIV-1; TM protein; cytoplasmic tail; oligomerization; packaging cell line.
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(INTRODUCTION
The human immunodeficiency virus type 1 (HIV-1) en-
velope (Env) glycoprotein is synthesized as a precursor,
gp160, which is folded, N-linked glycosylated, and oli-
gomerized. During transport to the cell surface, gp160 is
proteolytically cleaved to gp120 (SU) and gp41 (TM),
which are noncovalently linked. At the cell surface, ma-
ture Env proteins are preferentially incorporated into viral
particles. The maturation of the Env protein is critical to
the production of infectious viruses (Freed and Martin,
1995a; Swanstrom and Wills, 1997).
It has been reported that the mature Env protein con-
sists of a stable trimer containing SU–TM heterodimers
(Farzan et al., 1998; Lu et al., 1995; Tan et al., 1997;
Weissenhorn et al., 1997; Yang et al., 2000). Prior to
structural maturation of the TM domain (Otteken et al.,
1996), the Env precursor is oligomerized in the rough
endoplasmic reticulum through an amphipathic a-helical
equence called a “heptad repeat” (Chan et al., 1997; Earl
t al., 1991; Poumbourios et al., 1995; Weissenhorn et al.,
997). Several studies demonstrated that an Env protein-
ontaining mutation within the heptad repeat region was
1 Present address: Laboratory of Molecular Genetics, NICHD, Build-
ng 6B, Room 224, NIH, 9000 Rockville Pike, Bethesda, MD 20892-0460.
2 To whom correspondence and reprint requests should be ad-
dressed at the Laboratory of Gene Analysis, Department of Viral On-
cology, Institute for Virus Research, Kyoto University, Sakyo-Ku, KyotoR
606-8507, Japan. Fax: 181-75-751-3995. E-mail: hsakai@virus.Kyoto-
u.ac.jp.
45efective in mediating membrane fusion and virion entry,
lthough the mutant Env could be transported to the cell
urface and incorporated into virions. This indicates that
nv oligomerization is required for virus entry (Chen et
l., 1993; Freed et al., 1992; Layne et al., 1990). The fact
hat oligomerization is required for activity raises the
ossibility that some Env mutants could be dominant
egative, i.e., by forming a hetero-oligomer with wild-type
nv.
The TM protein of primate lentiviruses has a long
ytoplasmic tail (CT) region and in the case of HIV-1, it
onsists of approximately 150 amino acid residues. Sev-
ral studies indicated that the long CT region is impor-
ant for virion infectivity and that the region is required for
he efficient incorporation of Env into virions through an
nteraction with matrix (MA) protein (Dubay et al., 1992;
reed and Martin, 1996; Gabuzda et al., 1992; Yu et al.,
993). This result is supported by a variety of biochemical
Cosson, 1996; Vincent et al., 1999) and genetic studies
Dorfman et al., 1994; Freed and Martin, 1995b; Lee et al.,
997; Mammano et al., 1995; Murakami and Freed,
000a; Ono et al., 1997; Yu et al., 1992). An interaction
etween MA and CT is also supported by the observa-
ion that a tyrosine-based targeting signal in CT directs
he transport of Gag particles in polarized epithelial cells
Lodge et al., 1997; Owens et al., 1991). However, several
ther studies indicated that a large truncation of CT did
ot reduce either Env incorporation or virion infectivity
Freed and Martin, 1996; Murakami and Freed, 2000b;
eil et al., 1998), suggesting that Env incorporation is
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46 IWATANI ET AL.directed not only by an MA–CT interaction, but also by
CT-independent mechanisms.
Chen et al. reported that a CT-truncated Env formed a
omplex with wild-type Env; when the two proteins were
oexpressed in transfected cells, virions containing both
nv proteins appeared to be severely defective in an
arly infection phase, especially at the post-CD4 binding
tep (Chen et al., 1996). In this study, we analyzed the
henotype of virus containing hetero-oligomerized Env
roduced from a novel packaging cell line, in which
ild-type and mutant Env were expressed simulta-
eously. Analysis of the Env composition in virions
howed that CT-truncated Env could be incorporated in
ssociation with wild-type Env. In contrast to the results
btained by Chen et al., the coexpression of CT-trun-
ated and wild-type Env proteins did not significantly
nterfere with the virus infectivity. Therefore, we conclude
hat the CT-truncated Env did not function as a dominant-
egative mutant. We also describe the potential of an Env
utant lacking the gp160/gp41 cleavage site to function
s a dominant-negative mutant.
RESULTS
onstruction of a packaging cell line
To order to analyze the phenotype of virions that con-
ain both wild-type and CT-truncated Env proteins, both
roteins must be expressed in a single cell. This is
ecessary since it is difficult to exclude cells expressing
nly a single species of Env protein by cotransfection
echniques. To approach this issue, we established a
ew packaging cell line derived from HeLa cells which
llows both wild-type and mutant Env to be coexpressed
n a single cell. Using an infectious proviral DNA clone,
LAI, we constructed the pPACK plasmid, which was
ngineered as follows: (1) a packaging signal region
308–324 nt) was removed, (2) the first ATG codon of the
ev ORF was converted to ACG (no Rev expression), (3) a
ygromycin B phosphotransferase (hygr) gene was in-
serted into the nef ORF region (8491–8645 nt), and (4) the
vif gene was disrupted by a small truncation (4706–4990
nt). HeLa cells were transfected with pPACK DNA and
cell clones with an integrated copy of pPACK were ob-
tained by hygromycin B selection of cells expressing the
tat and hygr genes. Complementation of rev gene ex-
pression (e.g., by transfection of prev-1; Adachi et al.,
1996) in the cell clones triggers the expression of HIV-1
gene products (Gag, Pol, Env, and Vpr) from the inte-
grated pPACK. One of the isolated clones with these
properties was designated RIPH (Rev-inducible packag-
ing HeLa) (Fig. 1).
To verify the response of RIPH cells to rev expression,
the cells were transfected with various amounts of a
mutant proviral DNA (pDCT-104), which encodes CT-
mtruncated Env protein and provides the rev gene product
in trans. Gene expression derived from pPACK was as-
sessed by analyzing Env precursors in the cell lysate:
pPACK produces the wild-type gp160 precursor, whereas
pDCT-104 produces a truncated form of gp160 (Fig. 2A).
Without rev complementation, RIPH cells expressed very
little HIV-1 gp160; however, when the amount of pDCT-
104 was increased, the integrated copy of pPACK was
activated for expression of wild-type Env. When trans-
fected with 3–4 mg of pDCT-104, the RIPH cells ex-
ressed almost equivalent amounts of Env proteins from
oth pPACK and pDCT-104 (Fig. 2B). As a control for this
xperiment, we transfected RIPH cells with a rev expres-
ion plasmid, prev-1, and observed wild-type gp160 ex-
ression as shown in lane C (Fig. 2A). In addition, ex-
ression of other virus proteins, e.g., Gag and Pol, could
e induced by transfection of prev-1 alone (data not
hown).
omparison of virus infectivity in HeLa and
IPH cells
CT truncations have been reported to severely reduce
he virion infectivity of HIV-1. To evaluate the infectivity of
T-truncated mutant viruses, a reporter proviral DNA
ncoding the CAT gene, pLAInCAT(rev1), or its deriv-
tive encoding the CT-truncated Env protein, was
ransfected into HeLa cells; the resulting virions were
sed for infection of A3.01 cells. At 48 h after infection,
iral infectivity was determined by analyzing CAT ac-
ivity in infected cells. An env-deficient mutant,
LAInCAT(rev1)Denv, was employed as a negative
ontrol. As shown in Table 1 (HeLa), a small truncation
f up to 15 amino acids (aa) did not affect infectivity,
hile large truncations of 42–139 aa severely impaired
irion infectivity. The mutant viruses having these large
runcations failed to replicate in T cell lines, such as
3.01, H9, and CEMx174 cells (data not shown) (Dubay
t al., 1992; Yu et al., 1993). It was observed, however,
hat truncation of almost the entire CT region
DCT-143) restored the infectivity to 66.3% of the wild-
ype level.
We next analyzed the phenotypes of virions produced
rom RIPH cells transfected with a series of pLAInCAT-
rev1) derivatives. In contrast to virions containing a
ingle species of mutant or wild-type Env protein, virions
erived from RIPH cells, in which wild-type and CT-
runcated Env proteins were coexpressed, maintained a
evel of infectivity comparable to that of wild type (Table
, RIPH). This indicates that the CT-truncated Env protein
unctioned as a recessive factor and did not interfere
ith virion infectivity in the phenotypic mixing experi-
ent.
A mutant virus defective in gp120/gp41 cleavage,
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47ACTIVITY OF MUTANT ENV IN HIV-1 INFECTIONenvR515A, was reported to be deficient in infectivity,
because the mutant Env was devoid of membrane fusion
activity (Freed et al., 1989; Guo et al., 1990; McCune et al.,
988). The mutant virus produced from transfected HeLa
ells showed only 0.8% of wild-type infectivity (Table 1).
n phenotypic mixing experiments using RIPH cells, in-
orporation of R515A mutant Env almost completely
locked infectivity even though the wild-type Env protein
as expected to be expressed on the virion surface. This
esult suggested that the precursor form of Env protein
cted as a dominant-negative mutant for virion infectivity.
similar dominant-negative effect of the cleavage-de-
ective Env could be observed with virus obtained from
FIG. 1. Scheme for phenotypic expression in RIPH cells. pPACK DNA
ev gene and an insertion of a hygr gene in the nef gene region. In the
xpression of structural viral proteins can be triggered by complementa
bottom). The produced virions contain the viral components derived feLa cells cotransfected with pLAInCAT(rev1) and
envR515A (data not shown). hnalysis of Env incorporation into virions
In view of the above results, it was next of interest to
nalyze the mechanism by which the Env mutants af-
ected virion infectivity. The CT truncation had no appar-
nt effect on cell-associated viral protein expression in
ransfected HeLa cells, but it severely impaired the in-
orporation of Env into virions (Fig. 3, AIDS serum). This
uggests that reduction in Env incorporation may be a
ajor mechanism for regulation of virion infectivity by the
T region. In contrast to the effect observed with HeLa
ells, incorporation of Env into the virus particles pro-
uced by RIPH cells was not significantly affected by CT
Fig. 4, AIDS serum). These results indicated that the
ted in RIPH cells has mutations in the packaging signal region (C) and
e of rev expression, the RIPH cells express only tat and hygr (top). The
ev function, for example, through the transfection of HIV-1 proviral DNA
th the transfected provirus DNA and the integrated pPACK DNA.integra
absencetero-oligomer containing wild-type and CT-truncated
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48 IWATANI ET AL.Env proteins retained Env functions, including virion in-
corporation, attachment, membrane fusion, and penetra-
tion.
We have previously observed that the CT region is
involved in selective incorporation of mature Env pro-
teins into virions and that truncations in CT induce the
incorporation of Env precursor into virions (Iwatani et al.,
2001). To detect the incorporation of the Env precursor in
the current study, we used a monoclonal antibody (C8
mAb), obtained from Chessie 8 hybridoma cells, which
specifically recognizes the CT region of TM protein.
When the CT-truncated mutants were expressed in HeLa
cells, the incorporation of Env precursor into the virions
was stimulated (Fig. 3, Chessie 8). However, a much
smaller effect was observed with virions from RIPH cells.
Note that since the Env products derived from DCT-139
are missing the epitope for C8 mAb, mutant Env could
not be detected in the DCT-139 lane. The results of Fig.
3 raise the possibility that the full-length CT functions to
exclude gp160 precursor protein from virions.
Hetero-oligomeric Env is incorporated into virions
from RIPH cells
It has been reported that the ectodomain of TM protein
directs the oligomerization of HIV-1 envelope glycopro-
FIG. 2. Expression of gp160 in RIPH cells transfected with various
amounts of HIV-1 mutant proviral DNA. (A) RIPH cells were transfected
with the indicated amount of pDCT-104 or with 5 mg of prev-1 (lane C).
At 48 h after transfection, the cells were metabolically labeled with
[35S]methionine and cysteine. The cell lysates were immunoprecipi-
tated with C8 mAb, and the precipitated proteins were analyzed by
SDS–PAGE. The positions of wild-type and CT-truncated gp160 are
indicated. (B) The amounts of gp160 shown in A were quantified with an
image analyzer. The amount of wild-type gp160 obtained after trans-
fection of 1 mg of pDCT-104 was set at 1.tein (Bernstein et al., 1995; McInerney et al., 1998; Poum-
bourios et al., 1995, 1997; Weissenhorn et al., 1997; Yang
det al., 2000); this leads to the prediction that the CT-
truncated TM is incorporated into virions as a hetero-
oligomer with the wild type when produced in RIPH cells.
To confirm this possibility, we analyzed the virion-asso-
ciated TM proteins produced from RIPH cells by an
immunoprecipitation assay under conditions that main-
tain the oligomeric structures of TM proteins (see Mate-
rials and Methods). To identify the hetero-oligomeric TM
proteins, we constructed a proviral DNA, pLAIDC8,
which had two amino acid substitutions at the epitope
recognized by C8 mAb, and derivatives having CT trun-
cations, pLAIDC8 z DCT-42, pLAIDC8 z DCT-61, and
pLAIDC8 z DCT-104. The infectivities of these DC8 vi-
ruses produced from transfected HeLa cells appeared to
be similar to those of the parental LAI viruses, suggest-
ing that the mutation at the epitope did not significantly
modify TM function (data not shown). By using these DC8
clones in the RIPH cell system, the oligomers containing
wild-type TM protein could be precipitated with C8 mAb,
but homo-oligomers of the DC8 TM protein could not. As
shown in Fig. 5, the truncated TM proteins (DCT-42,
DCT-61, and DCT-104) having the DC8 mutation could be
coimmunoprecipitated with the wild type. These results
suggested that the CT-truncated TM proteins could be
incorporated in virions by forming hetero-oligomers with
wild-type TM. However, further biochemical studies will
be required to exclude the possibility that there was
some interaction among different homo-oligomers that
could result in coimmunoprecipitation.
DISCUSSION
In the present study, we investigated the effect of
phenotypic mixing of Env proteins on both virus infectiv-
TABLE 1
Infectivities of Mutant HIV-1 Produced by HeLa and RIPH Cells
Mutant
Number of
residues (aa)
Virus infectivity (%)a
HeLa RIPH
Wild type 151 100 100
DCT-2 149 78.6 6 5.5 91.2 6 3.8
CT-15 136 63.5 6 7.2 82.3 6 4.5
CT-42 109 9.4 6 10.5 81.4 6 9.6
CT-61 90 0.1 6 2.1 74.7 6 8.8
DCT-104 47 6.6 6 3.8 80.3 6 7.2
DCT-139 12 3.9 6 2.5 83.6 6 11.2
DCT-143 8 66.3 6 6.0 92.9 6 8.5
envR515A 151 0.8 6 3.0 4.7 6 1.2
Denv — 0 NDb
a To analyze virus infectivity, the CAT-expressing reporter virus
LAInCAT(rev1)) having CT mutation was used to infect A3.01 cells.
AT activity within the infected cells was monitored. A Denv mutant
LAInCAT(rev1)Denv) served as a negative control. The data represent
he averages of three independent experiments with the standard
eviation noted.
b ND, not determined.
p
ient se
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49ACTIVITY OF MUTANT ENV IN HIV-1 INFECTIONity and Env incorporation into virions, by using a novel
packaging cell line. The CT region of HIV-1 has been
reported to be important for virus infectivity. Thus, we
found that CT-truncated Env protein in the form of a
homo-oligomer severely impaired Env incorporation in
accord with earlier reports (Dubay et al., 1995; Freed and
Martin, 1996; Yu et al., 1993); however, such an effect was
not observed for hetero-oligomers containing wild-type
protein. In contrast to the results obtained with the CT-
truncated mutants, phenotypic mixing of a cleavage-de-
fective Env (R515A) with wild-type Env markedly sup-
pressed viral infectivity, suggesting that R515A Env is a
dominant-negative protein.
System for coexpression of wild-type and mutant Env
proteins in a single cell
To analyze the effect of mutant Env proteins present in
hetero-oligomers containing wild-type protein, it was
necessary to express both Env proteins in a single cell.
With conventional cotransfection, it is difficult to exclude
the cells transfected with only a single species of DNA,
which would affect the interpretation of the results. For
this purpose, we developed a novel packaging cell line,
designated RIPH. Only RIPH cells transfected with pro-
viral DNA clones encoding mutant env could express
both wild-type and mutant Env proteins simultaneously.
As illustrated in Figs. 1 and 2, it was observed that the
amount of mutant gp160 protein relative to that of the
FIG. 3. Radioimmunoprecipitation analysis of viral proteins in trans
roviral DNAs. At 48 h after transfection, the cells were metaboli
virion-associated viral proteins were immunoprecipitated with AIDS pat
indicate the positions of the viral proteins. C8 mAb could not bind to Dwild-type increased in proportion to the amount of trans-
fected DNA.We could also induce Gag protein by transfection of
prev-1 into RIPH cells (data not shown). In a similar
manner, the RIPH cell will be applied for studying the
effects of other viral mutant proteins on the interference
of virus infectivity and virus assembly, since both wild-
type and mutant proteins can be expressed simulta-
neously in a single RIPH cell but not by conventional
cotransfection technique.
CT-truncated mutant shows a recessive negative
mutant phenotype
In an earlier report, it was found that the hetero-
oligomeric complex of wild-type and CT-truncated Env
proteins in virions, which was produced by cotransfec-
tion experiments, appeared to be severely defective in
the post-CD4 binding step in the virus replication (Chen
et al., 1996). However, our result indicates that the infec-
tivity of viruses produced from RIPH cells, which express
both wild-type and CT-truncated Env proteins, was not
reduced (Table 1). Even with a 61-residue truncation,
virus infectivity was reduced to only 74.7% of the wild-
type level. This small reduction in infectivity can be ex-
plained by the reduced incorporation of Env proteins in
virions as shown in Fig. 4, rather than by a defect in an
early phase of viral replication caused by a dominant-
negative effect of the DCT-61 mutant. The discrepancy
between the paper by Chen et al. and our results might
be caused by a difference in the assay systems. Chen et
HeLa cells. HeLa cells were transfected with 10 mg of the indicated
beled with [35S]methionine and cysteine. The cell-associated and
rum (top) or C8 mAb (bottom) and analyzed by SDS–PAGE. The arrows
9 mutant Env, since it lacks the epitope for the mAb.fected
cally laal. used a cotransfection assay, whereas we have devel-
oped the RIPH cell system, in which the two Env proteins
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50 IWATANI ET AL.are expressed at a ratio of nearly 1:1. It is also possible
that higher levels of mutant protein expression are
needed to interfere with infectivity.
FIG. 4. Radioimmunoprecipitation analysis of viral proteins in transfec
NAs. At 48 h after transfection, the cells were metabolically labeled w
the integrated pPACK copy and the input plasmid DNA could be sim
phenotypically mixed virions (see schematic diagram in Fig. 1). The c
AIDS patient serum (top) or C8 mAb (bottom) and analyzed by SDS–PAG
derived from pDCT-139, which lacks the epitope for C8 mAb, could be
formation of a hetero-oligomer between wild-type and DCT-139 Env pr
FIG. 5. Detection of the hetero-oligomer of TM proteins in the virions
produced by RIPH cells. RIPH cells were transfected with 10 mg of the
ndicated proviral DNAs. Virions produced by HeLa cells transfected
ith pLAID8 served as a control. At 48 h after transfection, the cells
ere metabolically labeled with [35S]methionine and cysteine. The
irions produced in culture medium were lysed with 1% digitonin lysis
uffer, as described under Materials and Methods. The lysates were
mmunoprecipitated with C8 mAb and analyzed by SDS–PAGE. Note
hat C8 mAb could not directly recognize the DC8 TM proteins. As a
ontrol, RIPH cells were transfected with pLAIDgagDenv, which isp
c
efective in production of gag and env gene products. The positions of
gp160 and gp41 are shown with arrows.Cleavage-defective gp160 functions as a dominant-
negative mutant for virion infectivity
The precursor form of Env has been reported to be
able to bind to CD4 molecules, but not to induce mem-
brane fusion. Thus, it would appear that the mutant virus,
having an R515A substitution, lost the infectivity due to a
defect in virus entry process (Bosch and Pawlita, 1990;
Dubay et al., 1995; Freed et al., 1992; Iwatani et al., 2001;
cCune et al., 1988). In this study, the virions obtained
rom the RIPH cells transfected with penvR515A showed
nly 4.7% of the infectivity of the wild type, suggesting
hat the cleavage-defective gp160 (R515A) has a domi-
ant-negative effect on virion infectivity. However, it was
eported that a mutation at the cleavage site of gp160
educed by 57% the syncytium formation induced by
ild-type Env in a membrane fusion assay (Freed et al.,
992). This difference may be due to the fact that the
arget of the mutant Env in the dominant-negative effect
ould be different between the penetration of virus entry
nd the cell–cell fusion.
The infectivity of DCT-104 virus produced from HeLa
ells was severely impaired even though the virion-as-
ociated gp120 of DCT-104 virions from HeLa cells was
t a level similar to that of wild type (Table 1). We found
hat the CT truncation increased the incorporation of Env
H cells. RIPH cells were transfected with 10 mg of the indicated proviral
]methionine and cysteine. By using RIPH cells, viral proteins from both
ously expressed in the transfected cells, resulting in the release of
ciated and virion-associated proteins were immunoprecipitated with
positions of the viral proteins are indicated by arrows. The Env proteins
ted very faintly with C8 mAb (indicated with asterisks), indicating theted RIP
ith [35S
ultane
ell-asso
E. Therecursor into virions produced from transfected HeLa
ells (Fig. 3, virion-associated proteins detected with C8
51ACTIVITY OF MUTANT ENV IN HIV-1 INFECTIONmAb). Therefore, the reduced infectivity by CT truncation
might be responsible for the interference by nonspecifi-
cally incorporated precursor Env proteins as well as the
inhibition of gp120/gp41 incorporation.
CT-truncated Env protein could be incorporated into
virions as a form of oligomer with the wild type
The results shown in Fig. 4 clearly indicate that CT-
truncated TM proteins are incorporated into virions pro-
duced by RIPH cells expressing both wild-type and CT-
truncated TM proteins. However, it was difficult to deter-
mine whether the mutant protein formed a hetero-
oligomer with the wild type. To investigate whether the
hetero-oligomer of wild-type and CT-truncated Env pro-
teins was incorporated into virions, we performed an
immunoprecipitation assay, as described under Materi-
als and Methods. The assay indicated that the truncated
forms of TM proteins could be coprecipitated with the
wild type from virions produced by RIPH cells. This sug-
gests that the hetero-oligomer form of TM protein can be
incorporated into virions. The amount of CT-truncated
TM protein coprecipitated with wild type appeared to be
less than that of wild type alone (Fig. 5). This might be
due to incorporation of the homo-oligomer of wild-type
TM proteins. It has been shown that the function of the
CT region in Env incorporation was cell-type specific
(Murakami and Freed, 2000b). In that report, HeLa cells
were described as a permissive cell for CT truncation. In
our system with HeLa-derived cells, the CT-truncated
mutant oligomerized with the wild type did not signifi-
cantly affect Env incorporation, although it may be pos-
sible that the incorporation of the hetero-oligomeric Env
is modified in a cell-type-dependent manner.
In conclusion, in this report we have introduced a new
system, RIPH cells, to analyze the phenotype of viruses
containing both wild-type and mutant Env proteins. We
have also described the effects of CT-truncated and
gp120/gp41 cleavage-site mutants. The results obtained
with the cleavage-defective mutant showing a dominant-
negative effect on infectivity suggest that other hetero-
oligomeric viral proteins may also be exploited for de-
veloping inhibitors of virus infectivity. The RIPH cell sys-
tem will be useful for the research of such molecules.
MATERIALS AND METHODS
Plasmid construction
Full-length infectious DNA clone HIV-1 LAI, desig-
nated pLAI (kindly provided by Dr. Keith Peden), was
used in this study. The infectious DNA clones encod-
ing mutant Env with serial truncations in the CT region
were constructed using PCR-based oligonucleotide-
directed mutagenesis (Table 1). The sequences for
the 59 primers were 59(7948)-GGATATTCATGATTAT-
CGTTTCAG-39 (for pDCT-143), 59(7957)-CCATTATCGT-TCTAGACCCACCTC-39 (for pDCT-139), 59(8064)-GAA-
CGGATCCTGAGCACT-39 (for pDCT-104), 59(8191)-
GCCCTCAAATATTAGTGGAAT-39 (for pDCT-61),
59(8249)-CTGTTAGCTAGCTCAATGCC-39 (for pDCT-42),
59(8336)-TTCGCTAGATACCTAGGAGAATAAG-39 (for
pDCT-15), and 59(8365)-GGCTTGGAAAGGATCTA-
GATATAAGATGG-39 (for pDCT-2). The mutant proviral
HIV-1 DNA with a mutation at the cleavage site be-
tween gp120 and gp41 was constructed by oligonucle-
otide-directed mutagenesis. The sequence for the 59
primer was 59(7338)-GAGAGAAAAAGCTGCAGTGG-
GAATA-39 . The resulting construct, designated
penvR515A, could express a mutant Env protein having
a single amino acid change, R515A. This mutation
inactivates cleavage of the gp160 precursor to gp120
and gp41, as previously reported (Bosch and Pawlita,
1990; Dubay et al., 1995). pLAInCAT(rev1) is similar to
pNLnCAT (Adachi et al., 1996; Sakai et al., 1993), which
has an intact rev gene and a nef gene replaced by the
CAT gene. pLAInCAT(rev1)Dgag has a frame-shift mu-
tation at the ClaI restriction site (378 nt) in the gag
coding region. pLAInCAT(rev1)Denv has a frame-shift
mutation at a KpnI restriction site (5930 nt) in the env
coding region. The rev expression plasmid, prev1, was
described in an earlier report (Sakai et al., 1993). The
pLAIDC8 plasmid has a mutation in the epitope rec-
ognized by a monoclonal antibody (C8 mAb), which is
located in the CT region (the epitope sequence PDR-
PEG was substituted with PARPER) (Abacioglu et al.,
1994). The primer for the mutagenesis was 59(7987)-
CCGAGGGGACCCGCCAGGCCCGAAGGAATAGAA-
GAA. To establish packaging cells in which the virus
structural proteins were induced by rev expression, we
constructed a plasmid of HIV-1 proviral DNA, pPACK.
pPACK is described under Results.
Antibodies
Monoclonal antibody (C8 mAb) was affinity purified
from a hybridoma cell (Chessie 8) (Abacioglu et al., 1994),
which was obtained through the AIDS Research and
Reference Reagent Program, National Institute for Al-
lergy and Infectious Diseases. AIDS patient serum was
kindly provided by Dr. M. W. Cloyd (University of Texas
Medical Branch).
Cells and transfection
HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium (D-MEM) supplemented with 10% heat-
inactivated fetal bovine serum (FBS). The human CD41
cell line A3.01 was maintained in RPMI 1640 medium
supplemented with 10% heat-inactivated FBS. To estab-
lish a packaging cell, HeLa cells were transfected with a
plasmid of HIV-1 proviral DNA, pPACK, that was linear-
ized by XbaI. The transfected cells were selected in
D-MEM with 10% FBS plus 0.4 mg/ml hygromycin B.
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were transfected with prev-1 and then checked for the
expression of viral proteins both by indirect immunoflu-
orescence analysis and by radioimmunoprecipitation as-
say with AIDS patient serum. One of the highly express-
ing cells was chosen to use as a packaging cell in this
study. Routinely, the packaging cells, termed RIPH cells,
were maintained in D-MEM with 10% FBS plus 0.4 mg/ml
hygromycin B. We have occasionally observed that long-
term passage of RIPH cells reduces their ability to ex-
press viral proteins (data not shown). Therefore, cells
passaged more than 20 times were not used. As previ-
ously reported, transient transfections of adherent cell
lines were performed by the calcium phosphate method
(Adachi et al., 1996).
Single-round replication assay
HeLa or RIPH cells were transfected with 10 mg of
pLAInCAT(rev1) encoding wild-type or mutant env.
Two days after transfection, RT production in the cul-
ture supernatant was determined. An equivalent
amount of virions as measured by RT activity (corre-
sponding to approximately 10 ng of p24 by ELISA
(Cellular Products)) was used for infection of 2 3 106
A3.01 cells. At 48 h after infection, CAT activity in the
infected cell lysate was determined by a standard
assay. The activities obtained with env-deficient virus
derived from pLAInCAT(rev1)Denv were used as neg-
ative controls to eliminate the activity of Env-indepen-
dent uptake of virions.
Metabolic labeling and immunoprecipitation
At 48 h posttransfection of proviral DNA clones into
HeLa or RIPH cells, cells were labeled for 4 h with
[35S]methionine and [35S]cysteine (Redivue PRO-MIX
-[35S] in vitro cell labeling mix (Amersham Pharmacia
Biotech)). To study virion-associated Env, the superna-
tants were filtered through a 0.45-mm pore size filter and
he cell-free virus particles were pelleted in 1.5-ml micro-
ubes (4°C, 120 min, 16,000 g). The cells and virus par-
icles were lysed in RIPA buffer (150 mM NaCl, 50 mM
ris z HCl (pH 8.0), 1% Nonidet P-40, 0.5% sodium deoxy-
holate, 0.1% SDS, 1 mg/ml leupeptin, and 50 mg/ml
phenylmethylsulfonyl fluoride (PMSF)). For the analysis
of Env oligomers (Fig. 5), digitonin buffer (100 mM trieth-
anolamine, 150 mM NaCl, 1 mM EDTA, 1.0% digitonin, 10
mM iodoacetamide, 1 mg/ml leupeptin, and 50 mg/ml
PMSF) was used to lyse cells and virions. Immunopre-
cipitated proteins from cell and virion lysates with AIDS
patient sera or C8 mAb plus protein G–Sepharose were
separated on 8 or 10% polyacrylamide gels. The gel
image was obtained by exposure to BioMax MS films
(TranScreen was used for detection of virion-associated
viral proteins) (Eastman Kodak). FACKNOWLEDGMENTS
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